AQP9 and hepatocellular carcinoma: In HCC cells, lung carcinoma cells and leukemia cells, AQP9 was shown to be a transporter important for arsenic uptake, and its expression influenced the sensitivity of cells to arsenic treatment, thereby reducing the arsenic resistance of cancer cells [59,60,61].